Concord Wealth Partners - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$1,000
-50.0%
250.0%0.00%
-100.0%
Q1 2022$2,000
-33.3%
250.0%0.00%0.0%
Q4 2021$3,0000.0%250.0%0.00%0.0%
Q3 2021$3,000
+50.0%
250.0%0.00%0.0%
Q2 2021$2,0000.0%250.0%0.00%0.0%
Q1 2021$2,000
-33.3%
250.0%0.00%
-50.0%
Q4 2020$3,000250.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders